56,161 Shares in ZimVie Inc. (NASDAQ:ZIMV) Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC purchased a new position in shares of ZimVie Inc. (NASDAQ:ZIMVFree Report) during the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 56,161 shares of the company’s stock, valued at approximately $891,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Quarry LP grew its position in shares of ZimVie by 337.8% in the 2nd quarter. Quarry LP now owns 1,655 shares of the company’s stock worth $30,000 after buying an additional 1,277 shares during the last quarter. Summit Securities Group LLC grew its position in shares of ZimVie by 518.6% in the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock worth $55,000 after buying an additional 2,515 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of ZimVie in the 3rd quarter worth approximately $152,000. The Manufacturers Life Insurance Company bought a new stake in shares of ZimVie in the 2nd quarter worth approximately $191,000. Finally, WINTON GROUP Ltd bought a new stake in shares of ZimVie in the 2nd quarter worth approximately $209,000. 95.63% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Needham & Company LLC raised their target price on ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, August 2nd.

Get Our Latest Report on ZIMV

ZimVie Trading Up 3.1 %

ZIMV opened at $14.17 on Monday. The stock has a market cap of $391.08 million, a PE ratio of -1.08 and a beta of 2.14. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The business has a 50 day moving average of $14.88 and a 200-day moving average of $16.64. ZimVie Inc. has a 52 week low of $9.00 and a 52 week high of $22.40.

ZimVie Company Profile

(Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles

Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMVFree Report).

Institutional Ownership by Quarter for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.